Literature DB >> 14657005

25-hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells.

Yan-Ru Lou1, Ilkka Laaksi, Heimo Syvälä, Merja Bläuer, Teuvo L J Tammela, Timo Ylikomi, Pentti Tuohimaa.   

Abstract

According to the present paradigm, 1alpha,25-dihydroxyvitamin D3 [1alpha,25-(OH)2D3] is a biologically active hormone; whereas 25-hydroxyvitamin D3 (25OHD3) is regarded as a prohormone activated through the action of 25-hydroxyvitamin D3 1alpha-hydroxylase (1alpha-hydroxylase). Although the role of vitamin D3 in the regulation of growth and differentiation of prostatic epithelial cells has been well studied, its action and metabolism in prostatic stroma are still largely unknown. We investigated the effects of 25OHD3 and 1alpha,25-(OH)2D3 on two human stromal primary cultures termed P29SN and P32S. In a cell proliferation assay, 25OHD3 was found at physiological concentrations of 100-250 nM to inhibit the growth of both primary cultures, whereas 1alpha,25-(OH)2D3 at a pharmacological concentration of 10 nM exhibited the growth-inhibitory effects on P29SN cells but not on P32S cells. Quantitative real-time RT-PCR analysis revealed that both 25OHD3 and 1alpha,25-(OH)2D3 induced 25-hydroxyvitamin D3 24-hydroxylase (24-hydroxylase) mRNA in a dose- and time-dependent manner. By inhibiting 1alpha-hydroxylase and/or 24-hydroxylase enzyme activities, the induction of 24-hydroxylase mRNA by 250 nM 25OHD3 was clearly enhanced, suggesting that 1alpha-hydroxylation is not a prerequisite for the hormonal activity of 25OHD3. Altogether our results suggest that 25OHD3 at a high but physiological concentration acts as an active hormone with respect to vitamin D3 responsive gene regulation and suppression of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657005     DOI: 10.1096/fj.03-0140fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D--mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells.

Authors:  Shveta Taparia; James C Fleet; Ji-Bin Peng; Xiang Dong Wang; Richard J Wood
Journal:  Eur J Nutr       Date:  2005-12-21       Impact factor: 5.614

3.  Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status.

Authors:  Sarah Mordan-McCombs; Theodore Brown; Wei-Lin Winnie Wang; Ann-Christin Gaupel; Joellen Welsh; Martin Tenniswood
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-27       Impact factor: 4.292

Review 4.  25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance.

Authors:  Hulya Taskapan; Mingxin Wei; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture.

Authors:  Xinjian Peng; Michael Hawthorne; Avani Vaishnav; René St-Arnaud; Rajendra G Mehta
Journal:  Breast Cancer Res Treat       Date:  2008-01-20       Impact factor: 4.872

Review 6.  Molecular actions of vitamin D contributing to cancer prevention.

Authors:  James C Fleet
Journal:  Mol Aspects Med       Date:  2008-08-08

7.  Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites.

Authors:  Pentti Tuohimaa; Jing-Huan Wang; Sofia Khan; Marianne Kuuslahti; Kui Qian; Tommi Manninen; Petri Auvinen; Mauno Vihinen; Yan-Ru Lou
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

8.  Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase.

Authors:  Shuo Geng; Shuanhu Zhou; Julie Glowacki
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

9.  Vitamin d, sunlight and prostate cancer risk.

Authors:  Krishna Vanaja Donkena; Charles Y F Young
Journal:  Adv Prev Med       Date:  2011-06-08

10.  Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism.

Authors:  Saveria Aquila; Carmela Guido; Emilia Middea; Ida Perrotta; Rosalinda Bruno; Michele Pellegrino; Sebastiano Andò
Journal:  Reprod Biol Endocrinol       Date:  2009-11-30       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.